# clm_FB8452B2152F

subject: Gilead Sciences (/record/gilead-sciences.md)  
predicate: quarterly_revenue  
value: 7,042,000,000 United States dollar  
valid_from: 2022-09-30  
valid_to: 2023-03-31  
published: 2022-11-02  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_2124B66E70B5  
last_updated: 2026-11-08  
cite: AsOf. "Gilead Sciences quarterly revenue: 7,042,000,000 United States dollar", as of 2022-09-30 (until 2023-03-31). Claim clm_FB8452B2152F, https://asof.is/claim/clm_FB8452B2152F, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/882095/000088209522000027/0000882095-22-000027-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2022, filed 2022-11-02  

## Sources

- https://www.sec.gov/Archives/edgar/data/882095/000088209522000027/0000882095-22-000027-index.htm (primary, SEC EDGAR 10-Q Q3 FY2022, published 2022-11-02)

## Supersedes

- [Gilead Sciences](/record/gilead-sciences.md) | quarterly_revenue | 6,260,000,000 United States dollar | valid 2022-06-30 to 2022-09-30 | conf 0.95 | superseded | superseded_by [clm_FB8452B2152F](/claim/clm_FB8452B2152F.md) | [clm_DAC30FE4D631](/claim/clm_DAC30FE4D631.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.